Cargando…
Trailblazing Precision Oncology for Rare Tumor Subtypes
Molecular Tumor Boards seek to recommend therapeutics to patients based on varying levels of evidence linking specific genetic alterations to treatment response. This commentary highlights the study by Kato and colleagues, which reports the usage of precision medicine approaches in rare and ultra‐ra...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AlphaMed Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813755/ https://www.ncbi.nlm.nih.gov/pubmed/29158369 http://dx.doi.org/10.1634/theoncologist.2017-0494 |